Genetic Hair Loss Tests: What They Can and Can't Tell You

A genetic hair loss test can tell you something about your statistical likelihood of pattern hair loss, but it cannot tell you when you will lose hair, how much, or exactly which pattern you will end up with. Tests that claim to predict which drug will work for you rest on a smaller and less settled body of evidence. For most people, family history, a scalp examination and how your hair has changed over time already answer the practical questions better than a test, and none of these tests should be the main reason for a surgical decision.

What hair loss genetics actually look like

Androgenetic alopecia, the common pattern of hair loss in men and many women, runs strongly in families. Twin studies in men suggest that a large share of the variation in male pattern baldness is explained by genes rather than environment. That is the basis for genetic testing: if the genes matter so much, perhaps reading them can predict the future.

The difficulty is that there is no single "baldness gene." Large genome-wide association studies, many of them using data from hundreds of thousands of people, have identified hundreds of genetic regions linked to male pattern baldness. Each one nudges risk a little up or down. Your overall likelihood comes from the combined effect of many variants, plus factors that are not genetic at all.

The androgen receptor gene and the "mother's side" myth

One of the best-known contributors is the androgen receptor (AR) gene, which sits on the X chromosome. Men inherit their single X chromosome from their mother, which is where the popular idea that baldness "comes from your mother's side" originates. But most of the other contributing regions are on non-sex chromosomes, inherited from both parents. A bald father, a bald maternal grandfather and a full-haired uncle all tell you something; none of them settles it.

Women are less well studied

Female pattern hair loss also has a genetic component, but it is less well understood, and it can overlap with hormonal, thyroid, iron-related and other causes. Most published genetic prediction work has focused on men, so a test result for a woman may be even less informative. Our guide to how DHT drives hair loss explains the hormonal side.

Polygenic risk scores: probability, not prophecy

A consumer genetic test for hair loss usually reports some form of polygenic risk score, which adds up the effects of many variants into a single number or category such as "higher than average likelihood."

What that number can do is sort large groups of people into those more and less likely to develop significant hair loss. What it cannot do well is tell one individual what will happen to them. Plenty of people with a "high" score keep much of their hair, and some with an "average" score lose a lot. Scores also say little about timing, pattern or speed, which are exactly the things that matter for treatment and surgery planning.

There is also a ceiling on what any score can do. Even a perfect genetic test would not capture non-genetic influences, which is one reason predictions stay probabilistic.

Drug-response tests and the evidence

A second category of test claims to predict whether a treatment will work for you. The best-known example concerns minoxidil.

Minoxidil and sulfotransferase

Minoxidil is converted into its active form, minoxidil sulfate, by sulfotransferase enzymes, and the activity of these enzymes in hair follicles varies from person to person. Researchers have proposed that people with low follicular sulfotransferase activity are less likely to respond to topical minoxidil, and tests have been developed that measure enzyme activity in plucked hairs, or look at genetic variants in a sulfotransferase gene.

The idea is biologically plausible, and some small studies have reported that enzyme activity is associated with response. But the evidence base is limited: studies have been relatively small, some have been conducted by researchers with links to companies developing such tests, and independent confirmation in large, diverse groups is thin. Major dermatology guidelines do not, to our knowledge, recommend routine testing before starting minoxidil. Low-dose oral minoxidil, which some clinicians now prescribe, is also converted to its active form, but how well these tests apply to oral treatment is even less clear.

Finasteride and other treatments

Some tests look at variants in the androgen receptor gene or in genes involved in hormone metabolism and suggest they predict response to finasteride or dutasteride. The research here is mixed and has not settled into a reliable clinical tool. Our guide to the cost of waiting explains why a time-limited trial of treatment, supervised by a clinician, is how most people find out what works.

What you already know without a test

For practical decisions, most of the useful information is free or comes from a standard consultation:

• Family history on both sides, including the age when relatives started losing hair and how far it progressed.
• Your own history: when you first noticed thinning, and how fast it has changed. Dated photos help enormously.
• Pattern: where you are thinning now, judged against scales like the Norwood scale for men.
• Scalp examination: a clinician using a dermatoscope can look for miniaturized hairs, signs of active progression and signs of other conditions that mimic pattern loss.
• Blood work, when indicated: thyroid, iron and other tests can uncover contributing causes, especially for women.
• Response to treatment: how your hair changes over a fair trial of evidence-based therapy is the most direct answer to "will this drug work for me?"

Tests compared with an exam

Should a test shape surgery decisions?

A hair transplant moves a limited supply of donor hair to thinning areas. Good surgical planning depends on your current pattern, how stable it is, the quality and size of your donor area, your age, and a realistic view of how far loss may progress. A careful surgeon plans conservatively enough that the result still looks natural if you keep losing native hair.

A genetic score does not change that logic much. A "low risk" result is not a reason for a surgeon to design an aggressive, low hairline on a young patient, and a "high risk" result does not tell anyone how many grafts to hold in reserve. Those decisions should rest on examination, history and conservative planning. This matters most for younger patients in their 20s, whose final pattern is hardest to predict.

Be wary of any clinic that uses a genetic test as a sales tool, for example to argue you must have surgery now, or to justify a bigger session than the exam supports.

When a test might be a reasonable choice

A test is not harmful in itself, and some people find the information interesting. It may be a reasonable choice if:

• You are curious, can afford it comfortably, and will treat the result as one piece of background information.
• You and your clinician want an extra data point while deciding which treatment to try first, understanding its limits.
• You have little or no family history to go on, for example if you were adopted, and want some broad sense of likelihood.

It is probably not worth paying for if you expect it to tell you whether to have surgery, how many grafts you need, or whether to stop a treatment. Before buying, check what the company does with your genetic data, whether you can delete it, and whether results are reviewed by a clinician.

Frequently asked questions